PRIGOLEX Trademark

Trademark Overview

On Friday, December 11, 2009, a trademark application was filed for PRIGOLEX with the United States Patent and Trademark Office. The USPTO has given the PRIGOLEX trademark a serial number of 79078116. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, December 12, 2019. This trademark is owned by CSL Behring AG. The PRIGOLEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and substances for the treatment of blood or bleeding disorders; immunoglobulin for the treatment of immunodeficiency disorders and immune replacement therapy
prigolex

General Information

Serial Number79078116
Word MarkPRIGOLEX
Filing DateFriday, December 11, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, December 12, 2019
Registration Number3870343
Registration DateTuesday, November 2, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 17, 2010

Trademark Statements

Goods and ServicesPharmaceutical products and substances for the treatment of blood or bleeding disorders; immunoglobulin for the treatment of immunodeficiency disorders and immune replacement therapy
Translation of Words in MarkThe wording "PRIGOLEX" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 9, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCSL Behring AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH-3014 Bern
CH
Party NameCSL Behring AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH-3014 Bern
CH
Party NameCSL Behring AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH-3014 Bern
CH

Trademark Events

Event DateEvent Description
Friday, August 28, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, August 28, 2020DEATH OF INTERNATIONAL REGISTRATION
Friday, March 16, 2018TOTAL INVALIDATION PROCESSED BY THE IB
Friday, February 16, 2018TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, February 16, 2018INVALIDATION PROCESSED
Friday, February 9, 2018TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 9, 2017CANCELLED SECTION 71
Thursday, February 25, 2016NEW REPRESENTATIVE AT IB RECEIVED
Monday, April 8, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, February 10, 2013NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 14, 2011FINAL DISPOSITION NOTICE SENT TO IB
Monday, February 14, 2011FINAL DISPOSITION PROCESSED
Wednesday, February 2, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 2, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, August 17, 2010PUBLISHED FOR OPPOSITION
Wednesday, July 28, 2010NOTICE OF PUBLICATION
Friday, July 9, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 8, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 7, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 7, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 7, 2010ASSIGNED TO LIE
Thursday, June 17, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 9, 2010REFUSAL PROCESSED BY IB
Wednesday, March 17, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, March 17, 2010REFUSAL PROCESSED BY MPU
Wednesday, March 17, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 16, 2010NON-FINAL ACTION WRITTEN
Monday, March 15, 2010ASSIGNED TO EXAMINER
Tuesday, February 23, 2010APPLICATION FILING RECEIPT MAILED
Wednesday, February 17, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 11, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

prigolex disorders treatment therapy immunodeficiency immune immunoglobulin replacement bleeding products substances